88 related articles for article (PubMed ID: 9886866)
1. Desensitization of CGRP and adrenomedullin receptors in SK-N-MC cells: implications for the RAMP hypothesis.
Drake WM; Ajayi A; Lowe SR; Mirtella A; Bartlett TJ; Clark AJ
Endocrinology; 1999 Jan; 140(1):533-7. PubMed ID: 9886866
[TBL] [Abstract][Full Text] [Related]
2. Desensitization of adrenomedullin and calcitonin gene-related peptide receptors in vascular smooth muscle cells--effects of receptor activity-modifying protein.
Qi YF; Xue L; Chai SB; Shi YR; Pang YZ; Tang CS
Sheng Li Xue Bao; 2001 Oct; 53(5):396-400. PubMed ID: 11833426
[TBL] [Abstract][Full Text] [Related]
3. Desensitization and re-sensitization of CGRP receptor function in human neuroblastoma SK-N-MC cells.
Pin SS; Xu C; Bahr BA
Eur J Pharmacol; 2007 Dec; 577(1-3):7-16. PubMed ID: 17825280
[TBL] [Abstract][Full Text] [Related]
4. Desensitisation of calcitonin gene-related peptide responsiveness but not adrenomedullin responsiveness in vascular smooth muscle cells.
Drake WM; Lowe SR; Mirtella A; Bartlett TJ; Clark AJ
J Endocrinol; 2000 Apr; 165(1):133-8. PubMed ID: 10750043
[TBL] [Abstract][Full Text] [Related]
5. Progesterone upregulates calcitonin gene-related peptide and adrenomedullin receptor components and cyclic adenosine 3'5'-monophosphate generation in Eker rat uterine smooth muscle cell line.
Thota C; Yallampalli C
Biol Reprod; 2005 Feb; 72(2):416-22. PubMed ID: 15469997
[TBL] [Abstract][Full Text] [Related]
6. Novel peptide antagonists of adrenomedullin and calcitonin gene-related peptide receptors: identification, pharmacological characterization, and interactions with position 74 in receptor activity-modifying protein 1/3.
Robinson SD; Aitken JF; Bailey RJ; Poyner DR; Hay DL
J Pharmacol Exp Ther; 2009 Nov; 331(2):513-21. PubMed ID: 19644039
[TBL] [Abstract][Full Text] [Related]
7. A receptor activity modifying protein (RAMP)2-dependent adrenomedullin receptor is a calcitonin gene-related peptide receptor when coexpressed with human RAMP1.
Bühlmann N; Leuthäuser K; Muff R; Fischer JA; Born W
Endocrinology; 1999 Jun; 140(6):2883-90. PubMed ID: 10342881
[TBL] [Abstract][Full Text] [Related]
8. Desensitisation of adrenomedullin and CGRP receptors.
Hay DL; Poyner DR; Smith DM
Regul Pept; 2003 Apr; 112(1-3):139-45. PubMed ID: 12667635
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the expression of calcitonin receptor-like receptor (CRLR) and receptor activity modifying proteins (RAMPs) with CGRP and adrenomedullin binding in cell lines.
Choksi T; Hay DL; Legon S; Poyner DR; Hagner S; Bloom SR; Smith DM
Br J Pharmacol; 2002 Jul; 136(5):784-92. PubMed ID: 12086988
[TBL] [Abstract][Full Text] [Related]
10. Adrenomedullin and CGRP interact with endogenous calcitonin-receptor-like receptor in endothelial cells and induce its desensitisation by different mechanisms.
Nikitenko LL; Blucher N; Fox SB; Bicknell R; Smith DM; Rees MC
J Cell Sci; 2006 Mar; 119(Pt 5):910-22. PubMed ID: 16495482
[TBL] [Abstract][Full Text] [Related]
11. Protein kinase C is a common component of CGRP receptor desensitization induced by distinct agonists.
Pin SS; Bahr BA
Eur J Pharmacol; 2008 Jun; 587(1-3):8-15. PubMed ID: 18420188
[TBL] [Abstract][Full Text] [Related]
12. Structure-function analysis of amino acid 74 of human RAMP1 and RAMP3 and its role in peptide interactions with adrenomedullin and calcitonin gene-related peptide receptors.
Qi T; Ly K; Poyner DR; Christopoulos G; Sexton PM; Hay DL
Peptides; 2011 May; 32(5):1060-7. PubMed ID: 21402116
[TBL] [Abstract][Full Text] [Related]
13. Novel calcitonin-(8-32)-sensitive adrenomedullin receptors derived from co-expression of calcitonin receptor with receptor activity-modifying proteins.
Kuwasako K; Kitamura K; Nagoshi Y; Eto T
Biochem Biophys Res Commun; 2003 Feb; 301(2):460-4. PubMed ID: 12565884
[TBL] [Abstract][Full Text] [Related]
14. Aspartate(69) of the calcitonin-like receptor is required for its functional expression together with receptor-activity-modifying proteins 1 and -2.
Ittner LM; Luessi F; Koller D; Born W; Fischer JA; Muff R
Biochem Biophys Res Commun; 2004 Jul; 319(4):1203-9. PubMed ID: 15194494
[TBL] [Abstract][Full Text] [Related]
15. Identification of N-terminal receptor activity-modifying protein residues important for calcitonin gene-related peptide, adrenomedullin, and amylin receptor function.
Qi T; Christopoulos G; Bailey RJ; Christopoulos A; Sexton PM; Hay DL
Mol Pharmacol; 2008 Oct; 74(4):1059-71. PubMed ID: 18593822
[TBL] [Abstract][Full Text] [Related]
16. Effects of adrenomedullin on cyclic AMP formation and on relaxation in iris sphincter smooth muscle.
Yousufzai SY; Ali N; Abdel-Latif AA
Invest Ophthalmol Vis Sci; 1999 Dec; 40(13):3245-53. PubMed ID: 10586949
[TBL] [Abstract][Full Text] [Related]
17. Activation of adenylyl cyclase in human myometrial smooth muscle cells by neuropeptides.
Casey ML; Smith J; Alsabrook G; MacDonald PC
J Clin Endocrinol Metab; 1997 Sep; 82(9):3087-92. PubMed ID: 9284749
[TBL] [Abstract][Full Text] [Related]
18. Characterization and effects on cAMP accumulation of adrenomedullin and calcitonin gene-related peptide (CGRP) receptors in dissociated rat spinal cord cell culture.
Takhshid MA; Poyner DR; Chabot JG; Fournier A; Ma W; Zheng WH; Owji AA; Quirion R
Br J Pharmacol; 2006 Jun; 148(4):459-68. PubMed ID: 16702994
[TBL] [Abstract][Full Text] [Related]
19. Adrenomedullin and calcitonin gene-related peptide interact with the same receptor in cultured human neuroblastoma SK-N-MC cells.
Zimmermann U; Fischer JA; Muff R
Peptides; 1995; 16(3):421-4. PubMed ID: 7651894
[TBL] [Abstract][Full Text] [Related]
20. Adrenomedullin receptors in rat cerebral microvessels.
Kobayashi H; Minami S; Yamamoto R; Masumoto K; Yanagita T; Uezono Y; Tsuchiya K; Mohri M; Kitamura K; Eto T; Wada A
Brain Res Mol Brain Res; 2000 Sep; 81(1-2):1-6. PubMed ID: 11000473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
